ReviewOncoTargets and therapy2017

Spotlight on bevacizumab and its potential in the treatment of malignant pleural mesothelioma: the evidence to date.

Pavel A Levin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.